Treovir Inc. is developing G207, a novel oncolytic viral therapy aimed at treating pediatric glioblastoma and improving patient outcomes.
Learn about upcoming events and the latest news in tech. Delivered to your inbox weekly.
[embed]https://vimeo.com/1067797226[/embed] Building a successful startup often requires adaptability, resilience, and a clear vision — and Sport Feeds is a prime example of that journey. We ...
Innovation Depot is proud to kick off the 10th edition of Voltage, welcoming an incredible group of entrepreneurs ready to turn their tech ideas into ...
Birmingham, Ala. (October 22, 2024) – Innovation Depot is thrilled to announce the launch of the ninth iteration of its Voltage program, welcoming an impressive ...